Mr. Ananth Kumar (Minister of chemicals and fertilizers) was speaking at the inaugural of the 9th Medical Technology Conference organized , the medical technology manufacturers meeting would be held with ministers of health, environment and forest and finance to rectify the problems relating to banning imports of refurbished medical devices with extended warranty in the following days. According to CDSCO, for marketing of imported medical devices in India requires medical device Registration Certificate in Form-41 and Import License in Form-10 under the Drugs and Cosmetics Rules.
A recent government notification had banned the import of medical technologies more than 3 years old, causing widespread concern among the industry. Total production of medical equipment during the last two and half years has crossed US$ 2 billion. He also said that “People in Asia and Africa regions look forward to affordable and easily accessible medical devices to cater to their demanding health needs, which can be supplied from India,”
Mr. Ananth Kumar said that introduction of Goods and Services Tax (GST) could bring down the prices of medical equipment by 12 %. He recommends the industry to take an agreement approach on the regulatory mechanism needed for the sector and to create a mission mode approach to develop the medical devices segment. He also said that medical devices parks coming up in Gujarat and Andhra Pradesh would be game changers and wanted other states to follow that model.
Chairman of CII Medical Technology Division Himanshu Baid mentioned that, the Government is taking several steps to promote the medical devices sector in the country. However, there are concerns such as delay in setting up the regulatory body for medical devices, unwarranted regulations, like plastic bags ban in blood banks etc. which should be resolved.
Other News
India Medical Device Pricing Strategy: Ensuring Growth & Affordability
India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]
Read MoreImports of High-Value Medical Equipment
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC Committee: Pioneering Medical Approvals
New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
